However, deletion of ANGPTL4 in hepatocytes resulted in reduced TG levels and protected against diet-induced obesity, glucose intolerance, liver steatosis, and atherosclerosis, without the previously described complications of whole-body Angptl4 deficiency (123). Here, ANGPTL4 is linked to fatty liver disease.